Leupin Nicolas 4
4 · NovoCure Ltd · Filed Mar 3, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Leupin Nicolas
Former Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2025-02-27$19.92/sh−830$16,535→ 50,294 total - Sale
Ordinary Shares
2025-02-27$20.55/sh−161$3,308→ 50,133 total
Footnotes (2)
- [F1]On February 27, 2025, the reporting person sold 830 shares in multiple trades at prices ranging from $19.41 to $20.4033. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]On February 27, 2025, the reporting person sold 161 shares in multiple trades at prices ranging from $20.41 to $20.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.